201
Participants
Start Date
April 24, 2023
Primary Completion Date
May 30, 2024
Study Completion Date
May 1, 2026
Personalization of dose and frequency and instituting a tapering protocol of hydromorphone post-orthognathic surgery
POP participants will be given a personalized opioid prescription with a tapering protocol based on their last inpatient 24-hour usage of opioids, obtained from the nursing medication administration record. Should a participant stay in the hospital for less than 24 hours (e.g. patient had an early discharge at 18 hours), the 24-hour in-patient opioid usage would be extrapolated from their total amount and frequency of opioid use. The participant will be provided with an instruction card with suggestions on how much opioid to take at various time points following discharge to safely taper their medication.
Standardized dose and frequency of hydromorphone with no tapering post-orthognathic surgery
SOP participants will be given a standardized dose of hydromorphone (2-4mg orally every 6 hours), and a total amount of 40mg. No further information is provided to them with regards to their pain medication and to tapering.
Dalhousie University, Halifax
Nova Scotia Health Authority
OTHER